Diagnostics

Packets of the IT-Leish rapid diagnostic test (RDT) for visceral leishmaniasis are displayed against a gradient background transitioning from teal to purple. Each white packet is clearly labeled with identification details including "IT LEISH", lot numbers, and expiration dates, along with the IVD (in vitro diagnostic) symbol, emphasizing their use in medical diagnostics. The packets are partially overlapped, focusing on their essential information and sterile packaging.

GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid diagnostic test (RDT) for visceral leishmaniasis…

GADx formed to expand affordable access to advanced rapid diagnostic technologies

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in…

Mologic partners with FINDdx for schistosomiasis rapid test

Mologic partners with FINDdx for schistosomiasis rapid test

Neglected Tropical Diseases affect more than one billion people worldwide, in some of the poorest areas. According to the World Health Organisation, schistosomiasis is a disease of poverty that leads to chronic ill health and…

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global…